ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

Sledge Elected ASCO President

January 16, 2009

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

DCT board Oks New Cooperative Groups For MRI Evaluations In Breast Cancer

February 18, 1994

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980